Research Article

Slender Sheath/Guiding Catheter Combination vs. Sheathless Guiding Catheter for Acute Coronary Syndrome: A Propensity-Matched Analysis of the Two Devices

Table 1

Baseline clinical characteristics of the study population.

VariablesTotal populationPropensity-matched population
Glidesheath n = 397Sheathless n = 711Glidesheath n = 364Sheathless n = 364

Age, y68.0 (58.0–77.0)68.0 (58.0–77.0)0.8967.5 (57.3–76.0)67.0 (57.0–75.0)0.69
Sex (male), n (%)318 (80.1)554 (77.9)0.44292 (80.2)289 (79.4)0.85
Height, cm165.0 (160.0–170.0)164.5 (158.0–170.0)0.068165.7 (160.0–170.0)165.0 (158.0–170.0)0.23
Weight, kg67.0 (58.0–76.0)65.0 (57.0–74.0)0.1267.6 (58.0–77.0)66.8 (58.0–75.5)0.54
Body mass index, kg/m224.6 (22.3–27.2)24.3 (22.4–26.8)0.5124.6 (22.4–27.3)24.6 (22.6–27.4)0.64
Diabetes mellitus, n (%)167 (42.1)259 (36.4)0.071150 (41.2)157 (43.1)0.65
Hypertension, n (%)315 (79.4)557 (78.3)0.76286 (78.6)282 (77.5)0.79
Dyslipidemia, n (%)270 (68.0)475 (66.8)0.69243 (66.8)247 (67.9)0.81
Current smoker, n (%)171 (43.1)240 (33.8)0.002151 (41.5)152 (41.8)1.00
Peripheral artery disease, n (%)11 (2.8)24 (3.4)0.729 (2.5)12 (3.3)0.66
Previous history of bleeding, n (%)32 (8.1)59 (8.3)1.031 (8.5)32 (8.8)1.00
Previous history of heart failure, n (%)25 (6.3)36 (5.1)0.4118 (5.0)21 (5.8)0.74
Previous stroke, n (%)21 (5.3)45 (6.3)0.5120 (5.5)23 (6.3)0.75
Previous MI, n (%)27 (6.8)70 (9.9)0.09625 (6.9)28 (7.7)0.78
Previous PCI, n (%)52 (13.1)133 (18.7)0.01946 (12.6)46 (12.6)1.00
Previous CABG, n (%)3 (0.8)3 (0.4)0.673 (0.8)2 (0.6)1.00
Oral anticoagulants, n (%)39 (9.9)75 (10.6)0.7634 (9.3)35 (9.6)1.00
Killip IV on admission, n (%)13 (3.3)14 (2.0)0.229 (2.5)10 (2.8)1.00
eGFR, ml/min/1.73 m274.6 (59.3–91.0)75.1 (60.6–86.9)0.8775.4 (60.1–91.5)77.3 (62.8–88.8)0.72

Data are presented as median (interquartile range) or n (%), unless otherwise indicated. “Glidesheath” denotes 7-Fr Glidesheath slender/7-Fr guiding catheter combination group, and “Sheathless” denotes 7.5-Fr sheathless guiding catheter group. The asterisk denotes a statistically significant difference between the two groups. CABG, coronary artery bypass grafting; eGFR, estimated glomerular filtration rate; MI, myocardial infarction; PCI, percutaneous coronary intervention.